Treatment of refractory chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with low-dose interleukin-2

Treatment of refractory chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with low-dose interleukin-2

Refractory chronic graft-versus-host disease (cGVHD) is the complication of allogeneic hematopoietic stem cell transplantation (HCT) that signi ficantly impacts quality of life, may be associated with morbidity and mortality and has limited treatment options. 16 adult pts (median age 22, range 16 -...

Full description

Bibliographic Details
Main Authors: I. S. Moiseev, E. A. Burmina, Y. A. Tarakanova, Y. R. Zalyalov, A. G. Smirnova, O. V. Pirogova, S. N. Bondarenko, B. V. Afanasyev
Format: Article
Language:Russian
Published: Academician I.P. Pavlov First St. Petersburg State Medical University 2015-12-01
Series:Učenye Zapiski Sankt-Peterburgskogo Gosudarstvennogo Medicinskogo Universiteta im. Akad. I.P. Pavlova
Subjects:
аллогенная тгск
хроническая реакция «трансплантат против хозяина»
облитерирующий бронхиолит
интерелейкин-2
allogeneic hsct
chronic graft-versus-host disease
bronchiolitis obliterans
interleukin-2
Online Access:https://www.sci-notes.ru/jour/article/view/151

Internet

https://www.sci-notes.ru/jour/article/view/151

Similar Items